Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,428 | 1,107 | 98.6% |
| Education | $267.37 | 13 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,420 | 107 | $0 (2024) |
| ABBVIE INC. | $1,492 | 106 | $0 (2024) |
| Lilly USA, LLC | $1,406 | 98 | $0 (2024) |
| Novo Nordisk Inc | $1,265 | 107 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,047 | 55 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $742.10 | 52 | $0 (2024) |
| Alkermes, Inc. | $671.10 | 26 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $652.14 | 32 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $579.27 | 30 | $0 (2020) |
| Merck Sharp & Dohme LLC | $505.36 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,409 | 132 | ABBVIE INC. ($461.73) |
| 2023 | $2,441 | 132 | Alkermes, Inc. ($355.82) |
| 2022 | $2,810 | 154 | AstraZeneca Pharmaceuticals LP ($314.62) |
| 2021 | $2,296 | 141 | AbbVie Inc. ($401.78) |
| 2020 | $2,249 | 125 | AstraZeneca Pharmaceuticals LP ($677.69) |
| 2019 | $2,627 | 175 | AstraZeneca Pharmaceuticals LP ($398.53) |
| 2018 | $1,825 | 112 | Novartis Pharmaceuticals Corporation ($282.50) |
| 2017 | $2,038 | 149 | AstraZeneca Pharmaceuticals LP ($419.34) |
All Payment Transactions
1,120 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: Central Nervous System | ||||||
| 12/18/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Neurology | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/28/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Central Nervous System | ||||||
| 10/21/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/17/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: EPILEPSY | ||||||
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Neuroscience | ||||||
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 90 | 31,515 | 91,014 | $6.9M | $2.7M |
| 2022 | 77 | 21,721 | 45,745 | $3.5M | $1.6M |
| 2021 | 96 | 23,941 | 60,376 | $4.7M | $1.9M |
| 2020 | 93 | 24,749 | 66,992 | $4.0M | $1.7M |
All Medicare Procedures & Services
374 procedure records from CMS Medicare Utilization — Page 1 of 15
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 1,359 | 10,225 | $562,375 | $416,765 | 74.1% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 748 | 9,946 | $978,686 | $292,560 | 29.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 748 | 4,973 | $596,014 | $181,092 | 30.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 747 | 4,545 | $587,123 | $164,939 | 28.1% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 443 | 1,488 | $211,296 | $140,773 | 66.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 456 | 1,760 | $343,024 | $139,028 | 40.5% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 486 | 963 | $401,571 | $80,152 | 20.0% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 443 | 450 | $261,083 | $80,063 | 30.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 835 | 2,379 | $102,297 | $74,405 | 72.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 515 | 523 | $235,077 | $74,225 | 31.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 493 | 495 | $229,523 | $70,068 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 202 | 806 | $161,050 | $67,669 | 42.0% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 483 | 486 | $209,763 | $64,869 | 30.9% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 495 | 1,132 | $108,672 | $62,943 | 57.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 928 | 1,518 | $60,720 | $44,037 | 72.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 317 | 317 | $47,550 | $38,715 | 81.4% |
| 82747 | Folic acid level, rbc | Office | 2023 | 961 | 2,199 | $82,946 | $38,043 | 45.9% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 975 | 2,260 | $83,349 | $37,516 | 45.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 975 | 2,261 | $82,753 | $37,216 | 45.0% |
| 84432 | Thyroglobulin (thyroid related hormone) level | Office | 2023 | 975 | 2,260 | $79,010 | $35,572 | 45.0% |
| 99448 | Telephone or internet assessment with verbal and written report by consulting physician, 21-30 minutes | Office | 2023 | 418 | 843 | $109,245 | $34,471 | 31.6% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2023 | 876 | 2,787 | $69,675 | $32,901 | 47.2% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 961 | 2,199 | $72,171 | $32,501 | 45.0% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 961 | 2,199 | $92,358 | $29,379 | 31.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 968 | 2,207 | $64,356 | $28,956 | 45.0% |
About Dr. Imran Haque, M.D
Dr. Imran Haque, M.D is a Internal Medicine healthcare provider based in High Point, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134107022.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Imran Haque, M.D has received a total of $18,695 in payments from pharmaceutical and medical device companies, with $2,409 received in 2024. These payments were reported across 1,120 transactions from 87 companies. The most common payment nature is "Food and Beverage" ($18,428).
As a Medicare-enrolled provider, Haque has provided services to 101,926 Medicare beneficiaries, totaling 264,127 services with total Medicare billing of $7.9M. Data is available for 4 years (2020–2023), covering 374 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location High Point, NC
- Active Since 01/03/2006
- Last Updated 01/28/2026
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1134107022
Products in Payments
- FARXIGA (Drug) $1,447
- ENTRESTO (Drug) $870.63
- Ozempic (Drug) $702.66
- VRAYLAR (Drug) $597.43
- MOUNJARO (Drug) $464.13
- ARISTADA (Drug) $457.75
- TRELEGY ELLIPTA (Drug) $438.14
- JARDIANCE (Drug) $434.82
- LONHALA MAGNAIR (Drug) $422.24
- XARELTO (Drug) $410.69
- UBRELVY (Drug) $374.30
- AUSTEDO (Drug) $373.39
- SYMBICORT (Drug) $322.40
- TRULICITY (Drug) $321.49
- INGREZZA (Drug) $304.71
- QULIPTA (Drug) $297.62
- ELIQUIS (Drug) $274.52
- INVOKANA (Drug) $269.08
- BREZTRI (Drug) $261.29
- NUEDEXTA (Drug) $258.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in High Point
Dr. Jeffrey Yourshaw, M.d, M.D
Internal Medicine — Payments: $12,650
Dr. Oscar Florendo, M.d, M.D
Internal Medicine — Payments: $11,971
Thomas Jarrett, M.d, M.D
Internal Medicine — Payments: $9,588
Kurt Daniel, D.o, D.O
Internal Medicine — Payments: $7,198
Dr. William Smith, M.d, M.D
Internal Medicine — Payments: $6,941
Dr. Fernando Sanchez-Brugal, Md, MD
Internal Medicine — Payments: $6,214